Boston Pharmaceuticals Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 72

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 2

  • Investments
  • 2

Boston Pharmaceuticals General Information

Description

Operator of a drug development company intended to acquire clinical assets at various stages of their development. The company partners with academic, biotech and biopharma groups to develop new medicines by acquiring and transforming innovative molecules across multiple therapeutic areas, providing differentiated solutions that improve patients' lives.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 55 Cambridge Parkway
  • Suite 400
  • Cambridge, MA 02142
  • United States
+1 (617) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Boston Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Boston Pharmaceuticals‘s full profile, request access.

Request a free trial

Boston Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a drug development company intended to acquire clinical assets at various stages of their development. The c
Drug Discovery
Cambridge, MA
72 As of 2021
00000
0000000 0000 00000

00000

dipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqu
0000 000000000
Watertown, MA
000 As of 0000
00.000
0.00 0000-00-00
000000&0 00.000

000000

mpor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
0000 000000000
Cambridge, United Kingdom
00 As of 0000
00000
0000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Boston Pharmaceuticals Competitors (37)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Forma Therapeutics Corporate Backed or Acquired Watertown, MA 000 00.000 000000&0 00.000
Mission Therapeutics Venture Capital-Backed Cambridge, United Kingdom 00 00000 0000000000 00000
Cycle pharma Corporation Cambridge, United Kingdom 000
Novartis Corporation Basel, Switzerland 00000 0000 000000000 0000
Lead Pharma Venture Capital-Backed Oss, Netherlands 00 000.00 0000000000 000.00
You’re viewing 5 of 37 competitors. Get the full list »

Boston Pharmaceuticals Patents

Boston Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019202447-B2 Binding molecules specific for il-21 and uses thereof Active 08-Apr-2014 00000000000
AU-2015244025-B2 Binding molecules specific for il-21 and uses thereof Active 08-Apr-2014 00000000000
AU-2015244025-A1 Binding molecules specific for il-21 and uses thereof Active 08-Apr-2014 00000000000
US-10022443-B2 Antibodies specific for il-21 and uses thereof Active 08-Apr-2014 00000000000 0
AU-2019202447-A1 Binding molecules specific for il-21 and uses thereof Active 08-Apr-2014 A61K39/3955
To view Boston Pharmaceuticals’s complete patent history, request access »

Boston Pharmaceuticals Executive Team (14)

Name Title Board Seat Contact Info
Sophie Kornowski Ph.D Chief Executive Officer & Co-Chairman
Scott Allen Chief Financial Officer
Amanda Kunevich Chief People Officer
Juan Lopez-Talavera Ph.D Chief Medical Officer
Christopher Viehbacher Co-Founder
You’re viewing 5 of 14 executive team members. Get the full list »

Boston Pharmaceuticals Board Members (10)

Name Representing Role Since
00000 00000 Self Board Member 000 0000
00000 00000000 00 Boston Pharmaceuticals Board Member & Scientific Advisor 000 0000
000000 0000 00 Gurnet Point Capital Board Member 000 0000
000000 000000000 0 Boston Pharmaceuticals Chief Executive Officer & Co-Chairman 000 0000
000000 0000000 Self Co-Chairman 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Boston Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Boston Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Boston Pharmaceuticals‘s full profile, request access.

Request a free trial

Boston Pharmaceuticals Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Novartis (Candidate MAK181) 03-Oct-2018 0000000000 Buildings and Property 000000 00
Novartis (Worldwide Rights to LYS228, IID572 and MAK181) 03-Oct-2018 Merger/Acquisition Buildings and Property 000000 00
To view Boston Pharmaceuticals’s complete acquisitions history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »